A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK

BMC Musculoskeletal Disorders

Volumn 17, Issue 1, 2016, Pages

  Subesinghe, Sujith ^a,b   Rutherford, Andrew Ian ^c   Ibrahim, Fowzia ^b   Harris, Helen ^d   Galloway, James ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d NHS FIFE   (United Kingdom)

Author keywords

Infection; Influenza vaccines; Pneumococcal vaccines; Rheumatoid arthritis

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGEN LOAD; PNEUMOCOCCAL INFECTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SEASONAL INFLUENZA; UNITED KINGDOM; VACCINATION; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; INFLUENZA; MULTICENTER STUDY;

AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 84982728026     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/s12891-016-1187-4     Document Type: Article

References (26)

1. Scott DL, Wolfe F, Huizinga TWJ. Rheumatoid arthritis. Lancet. 2010;376:1094-108.
2. Young A, Koduri G, Batley M, Kulinskaya E, Gough A, Norton S, Dixey J, Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatol. 2007;46:350-7.
3. Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287-93.
4. Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA. The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol. 2008;35:387-93.
5. Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis. 2007;66:308-12.
6. Starkebaum G. Chronic neutropenia associated with autoimmune disease. Semin Hematol. 2002;39:121-7.
7. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998;95:14447-52.
8. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 2000;97:9203-8.
9. Au K, Reed G, Curtis JR, Kremer JM, Greenberg JD, Strand V, Furst DE, CORRONA Investigators. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:785-91.
10. Dixon WG, Watson K, Lunt M, Hyrich KL, Silmanm AJ, Symmons DPM. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006;54:2368-76.
11. Thomas E, Symmons DPM, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: A 20 year followup study. J Rheumatol. 2003;30:958-65.
12. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, Saikku P. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56:296-301.
13. Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, Lim WS. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012;67:540-5.
14. Sowden E, Mitchell WS. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord. 2007;8:58.
15. Haroon M, Adeeb F, Eltahir A, Harney S. The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics. Joint Bone Spine. 2011;78:374-7.
16. Thomas LM, Wood A, Shenton S, Ledingham JM. Uptake of influenza vaccination in rheumatology patients: reply. Rheumatology. 2005;44:131.
17. Findlay PF, Gibbons YM, Primrose WR, Ellis G, Downie G. Influenza and pneumococcal vaccination: patient perceptions. Postgrad Med J. 2000;76:215-7.
18. Housden MM, Bell G, Heycock CR, Hamilton J, Saravanan V, Kelly CA. How o reduce morbidity and mortality fro chest infections in rheumatoid arthritis. Clin Med. 2010;10:326-9.
19. Dexter LJ, Teare MD, Dexter M, Siriwardena AN, Read RC. Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice. BMJ Open. 2012;2:e000851.
20. Subesinghe S, Whittaker M, Galloway J. Mitigating infection risk with immunotherapy in rheumatoid arthritis. Int J Clin Rheum. 2015;10:177-93.
21. Strangfeld A, Eveslage M, Schneider M, Bergerhausen HJ, Klopsch T, Zink A, Listing J. Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient? Ann Rheum Dis. 2011;70:1914-20.
22. Zink A, Manger B, Kaufmann J, Eisterhues C, Krause A, Listing J, Strangfeld A. Evaluation of the RABBIT Risk Score for serious infections. Ann Rheum Dis. 2014;73:1673-6.
23. Whittaker M, Galloway J, Subesinghe S. Systematic review of the effect of anti-rheumatic therapies upon vaccine immunogenicity. Arthritis Rheum. 2014;66:S898-9.
24. Coulson E, Saravanan V, Hamilton J, Long KS, Morgan L, Heycock C, Kelly C. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70:1289-91.
25. Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia. Ann Rheum Dis. 2006;54:628-34.
26. Dixon WG, Abrahamowicz M, Beauchamp M-E, Ray DW, Bernatsky S, Suissa S, Sylvestre M-P. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012;71:1128-33.